🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of the current study is to investigate the efficacy, safety a...
Status
Completed
Location
1218.20.10033 Boehringer Ingelheim Investigational Site
Start Date
2008-02
Trial ID
NCT00622284
The primary objective is to demonstrate, after 52 weeks of treatment, the n...
Status
Terminated
Location
Sanofi-Aventis Administrative Office
Start Date
2007-03
Trial ID
NCT00449605
Treatments Being Tested
Phase IIIb, randomized, multicenter, double-blind, prospective study to eva...
Status
Completed
Location
Centro de Investigación y Avances Médicos Especializados
Start Date
2023-03-21
Trial ID
NCT04841096
Primary Objective: To evaluate the change in plasma levels of adiponectin ...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2010-12
Trial ID
NCT01204580
Treatments Being Tested
The pharmacokinetics of glimepiride and metformin will be compared after si...
Status
Completed
Location
Seoul National University Hospital
Start Date
2008-10
Trial ID
NCT00934323
Treatments Being Tested
Type 2 diabetic patients who fast during Ramadan experience swings in glyca...
Status
Completed
Location
Endocrinology Unit & Diabetes Management Centre, Services Hospital.
Start Date
2011-08
Trial ID
NCT01624116
Treatments Being Tested
This study will evaluate the efficacy and tolerability of saxagliptin compa...
Status
Completed
Location
Research Site
Start Date
2009-10
Trial ID
NCT01006603
Treatments Being Tested
The process of atherosclerosis is multifactorial and involves many mechanis...
Status
Withdrawn
Location
Hospital Clínico San Carlos
Start Date
2012-05
Trial ID
NCT01593137
Treatments Being Tested
The purpose of the study is to determine the effect of glimepiride on dapag...
Status
Completed
Location
Local Institution
Start Date
2008-05
Trial ID
NCT00562250
Treatments Being Tested
The objective of the study is to test the efficacy, safety and tolerability...
Status
Completed
Location
1218.6.3302A Boehringer Ingelheim Investigational Site
Start Date
2006-04
Trial ID
NCT00309608
Treatments Being Tested